obesity drug news today glp-1 2025 sep 30 Use of diabetes and anti-obesity drugs surges nationwide Alarming rise in weight loss

Arvanitakis KD, Arvanitaki AD, Karkos CD, Zintzaras E, Germanidis GS

Although the use of DPP-4 inhibitors is associated with increased bone formation, their effects are more associated with mechanisms related to the suppression of bone resorption

Winkler Cohen)

Mice with PD induced by 1,2,3,6 tetrahydro-1-methyl-4-phenylpyridine (MPTP) were treated with liraglutide and lixisenatide, which are GLP-1RA mimetics

While possible, maintaining results after stopping GLP-1 therapy is challenging and requires intensive lifestyle modifications including 200-300 minutes of weekly exercise, consistent dietary changes, regular self-monitoring, and often ongoing behavioral support

Data availability The Helsinki Biobank can provide access for research projects within the scope regulated by the Finnish Biobank Act, which is research utilizing the biobank samples or data for the purposes of promoting health, understanding the mechanisms of disease or developing products and treatment practices used in health and medical care